Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02975973 · ClinicalTrials.gov registry record · NA

Prefrontal Cortical Engagement Through Non-Invasive Brain Stimulation in Schizophrenia

A NA study, sponsored by Baylor College of Medicine.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT02975973 is a NA study that has completed, run by Baylor College of Medicine. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02975973, a NA study, has completed, sponsored by Baylor College of Medicine.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

Cognitive impairments in schizophrenia are the most debilitating aspect of the illness and poorly treated by current medications. This study investigates transcranial direct current stimulation (tDCS) - a safe, noninvasive weak electrical current delivery to stimulate brain function - as a novel therapeutic for cognition in schizophrenia. Integrating neurostimulation, electrophysiology and neuroimaging, this project aims to study tDCS effects on cognition by verifying therapeutic target engagement, evaluating the tolerability of tDCS sessions, and optimizing treatment parameters.

Interventions

  • DEVICE transcranial direct current stimulation

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2016-11
Est. Completion 2019-06
Phase NA

Sponsor

Baylor College of Medicine

616 total trials

What the Registry Record Tells You About NCT02975973

The ClinicalTrials.gov registry entry for NCT02975973 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which transcranial direct current stimulation is the first listed.

NCT02975973 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02975973 about?

NCT02975973 is a clinical study titled "Prefrontal Cortical Engagement Through Non-Invasive Brain Stimulation in Schizophrenia". Cognitive impairments in schizophrenia are the most debilitating aspect of the illness and poorly treated by current medications. This study investigates transcranial direct current stimulation (tDCS) - a safe, noninvasive weak electrical current delivery to stimulate brain function - as a novel the...

What is the current status of trial NCT02975973?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2016-11. Estimated completion is 2019-06.

What interventions are being tested in trial NCT02975973?

The interventions under investigation include: transcranial direct current stimulation (DEVICE).

Who is sponsoring clinical trial NCT02975973?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.